# Raloxifene Hydrochloride

NDC: 69097-825
Generic name: Raloxifene
Labeler / Manufacturer: Cipla USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20160629

FDA application: ANDA090842

## Active ingredients

- RALOXIFENE HYDROCHLORIDE: 60 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69097-825"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69097-825
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8fef5bfd-a786-4442-b09b-f3b81812cdac